What’s Driving Growth in the Aduhelm Market? Insights into Key Trends and Opportunities
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the aduhelm market grown in recent years?
In the past few years, the Aduhelm market has seen a XX (HCAGR). The market, which was worth $XX million in 2024, is projected to increase to $XX million in 2025, with a compound annual growth rate (CAGR) of XX%. Various factors are attributed to this historic growth, including a high prevalence of the disease, a noticeable demographic shift, the introduction of new therapeutic products, an increase in government funding and initiatives, and increased contributions by both private and government entities.
How is the aduhelm market size expected to evolve during the forecast period?
In the upcoming years, the Aduhelm market is predicted to experience a compound annual growth rate (CAGR) of XX%, raising its value to $XX million by 2029. The growth during this forecast period can be accredited to factors such as the escalating incidence of Alzheimer’s disease, an increasing elderly population, a heightened focus on early detection and intervention, amplified awareness about mental health issues, and more research & development initiatives. Key trends during this period are anticipated to be the emergence of fresh technologies, innovative treatment methods, advancements in diagnosing and treating Alzheimer’s patients, the integration of telemedicine, and breakthroughs in personalized medicine and gene therapies.
Get your aduhelm market report here!
https://www.thebusinessresearchcompany.com/report/aduhelm-global-market-report
Which key drivers are propelling the aduhelm market’s growth?
The growth of the aduhelm market is anticipated to surge due to the increasing incidences of Alzheimer’s disease. Alzheimer’s disease, a progressively degenerative neurological disorder, is characterized by cognitive function decline in areas such as memory, reasoning, and behavior. The rise in Alzheimer’s disease can be attributed to a variety of intertwined reasons, predominantly influenced by demographic, medical, and societal aspects. Aduhelm (aducanumab-avwa) is utilized in Alzheimer’s disease management as it targets and diminishes amyloid-beta plaques in the brain, thought to play a significant role in the disease’s progression. For instance, it was reported by the Alzheimer Society, a UK-based dementia support organization, in May 2024, that approximately 982,000 individuals in the UK are currently living with dementia. This number is projected to rise to 1.4 million by 2040. Consequently, the increasing incidences of Alzheimer’s disease are propelling the Aduhelm market’s expansion.
What are the market segments in the aduhelm industry?
The aduhelmmarket covered in this report is segmented –
1) By Indication: Mild Cognitive Impairment; Mild Dementia
2) By Distribution Channel: Hospitals And Clinics; Retail And Specialty Pharmacies
3) By End User: Adult; Geriatric
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19857&type=smp
Which leading companies are shaping the growth of the aduhelm market?
Major companies operating in the aduhelm market include Biogen Inc., Eisai Co. Ltd.
What key trends are currently impacting the aduhelm market’s development?
The prevailing shift in the Aduhelm market is the concentration on securing regulatory authorizations to enhance the reachability and obtainability of the treatment, thereby propelling the market’s evolution. Regulatory permissions pertain to the formal permission given by the government or regulatory entities (like the FDA in the U.S or the EMA in Europe) that permit a medication or therapeutic intervention to be sold and utilized within a unique area. For example, in June 2021, Biogen Inc., an American biotech firm collaborated with Eisai Co. Ltd., a Japanese pharmaceutical company, secured approval for Aduhelm (aducanumab) for Alzheimer’s disease treatment. Biogen orchestrated the clinical assessments and regulatory submissions for Aduhelm, which aims at amyloid plaques in the brain, suspected of inducing Alzheimer’s disease. It functions by adhering to clustered forms of amyloid-beta (Aβ) proteins, which create plaques in the brain of Alzheimer’s patients. By targeting these plaques, Aduhelm seeks to aid their eradication from the brain, potentially decelerating the disease’s progression.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19857
Which geographic areas are influencing the growth of the aduhelm market?
North America was the largest region in the aduhelm market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aduhelm market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Alzheimer’s Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/alzheimers-drugs-global-market-report
Alzheimer’s Disease Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/alzheimer-disease-treatment-global-market-report
Traumatic Brain Injury Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/traumatic-brain-injury-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: